ATAI Life Sciences
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $749 | $719 | $1,555 | $-5 |
Gross Profit | 749 | 719 | -9,283 | -5 |
EBITDA | -60,734 | -27,162 | -19,054 | -38,007 |
EBIT | -60,967 | -27,389 | -19,270 | -38,232 |
Net Income | -61,074 | -27,729 | -26,431 | -38,958 |
Net Change In Cash | 749 | 719 | 1,555 | -5 |
Free Cash Flow | -28,624 | -19,221 | -18,109 | -24,384 |
Cash | 30,402 | 61,940 | 48,287 | 17,505 |
Basic Shares | 217,601 | 196,563 | 176,271 | 160,159 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $308 | $314 | $233 | $20,376 |
Gross Profit | 308 | 314 | 233 | 20,376 |
EBITDA | -144,808 | -36,311 | -134,091 | -120,278 |
EBIT | -145,281 | -36,630 | -134,259 | -120,325 |
Net Income | -149,269 | -40,224 | -152,385 | -167,808 |
Net Change In Cash | 308 | 314 | 233 | 20,376 |
Cost of Revenue | -170,530 | |||
Free Cash Flow | -82,532 | -84,708 | -105,491 | -64,374 |
Cash | 17,505 | 45,034 | 190,613 | 362,266 |
Basic Shares | 160,159 | 158,833 | 155,719 | 160,677 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $0 |
2025-09-30 | -$0.28 |
2025-06-30 | -$0.14 |
2025-03-31 | -$0.15 |
